000 01752 a2200481 4500
005 20250515095807.0
264 0 _c20080422
008 200804s 0 0 eng d
022 _a0013-7227
024 7 _a10.1210/en.2007-0656
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMontessuit, Christophe
245 0 0 _aNuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
_h[electronic resource]
260 _bEndocrinology
_cMar 2008
300 _a1064-74 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAMP-Activated Protein Kinase Kinases
650 0 4 _aAlitretinoin
650 0 4 _aAnimals
650 0 4 _aCells, Cultured
650 0 4 _aCytoskeleton
_xdrug effects
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlucose Transporter Type 4
_xmetabolism
650 0 4 _aInsulin
_xphysiology
650 0 4 _aInsulin Resistance
_xphysiology
650 0 4 _aMale
650 0 4 _aMicrotubules
_xdrug effects
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aPPAR gamma
_xagonists
650 0 4 _aPhenoxyacetates
_xpharmacology
650 0 4 _aProtein Kinases
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRetinoid X Receptors
_xagonists
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aThiazolidinediones
_xpharmacology
650 0 4 _aTretinoin
_xpharmacology
700 1 _aPapageorgiou, Irène
700 1 _aLerch, René
773 0 _tEndocrinology
_gvol. 149
_gno. 3
_gp. 1064-74
856 4 0 _uhttps://doi.org/10.1210/en.2007-0656
_zAvailable from publisher's website
999 _c17577703
_d17577703